The Kronos Early Estrogen Prevention Study (KEEPS) is one of the most important modern menopause studies. It investigated hormone therapy in recently menopausal women and explored how different hormone formulations may influence health outcomes, symptoms and quality of life.
The KEEPS trial enrolled healthy women who were relatively close to menopause and compared different hormone therapy approaches with placebo.
Researchers wanted to better understand:
Following the WHI study, many clinicians questioned whether results from older women could be applied to younger women who were newly menopausal.
The KEEPS trial focused specifically on women closer to menopause, helping researchers understand outcomes in a different population.
The study evaluated different hormone therapy formulations and routes of administration.
This was important because hormone therapy is not a single treatment. Different formulations, doses and delivery methods may have different effects.
Modern menopause care increasingly recognises these differences when developing personalised treatment plans.
Women closer to menopause may differ from women many years beyond menopause.
Different hormone products should not automatically be viewed as identical.
Symptoms, risks and treatment goals should guide decisions.
The KEEPS trial helped move menopause medicine toward a more personalised approach.
Instead of asking:
Modern clinicians increasingly ask:
This represents a significant shift in menopause care and reflects how treatment decisions are increasingly individualised.
The KEEPS trial reinforced the importance of matching the right treatment to the right patient at the right time.
Book Assessment Browse Research Library